AI Telephone

Emily Chen is a 28-year-old woman with confirmed, active mild intermittent asthma without complications, present since childhood. Her current asthma medications include an albuterol inhaler, 90 mcg per actuation, taken as 2 puffs by inhalation as needed for shortness of breath, typically used 2–3 times per week. She also takes montelukast 10 mg orally once daily for asthma maintenance. Her last pulmonary function test showed a forced expiratory volume in 1 second (FEV1) of 92% of predicted. She has no known drug allergies, as confirmed in the record.

Emily Chen, a 28-year-old female, has active mild intermittent asthma with onset in childhood. She is prescribed albuterol 90 MCG per actuation inhaler, 2 puffs as needed for shortness of breath, and montelukast 10mg daily. Her FEV1 is 92% of predicted value.

Clinical Narrative

Emily Chen is a female patient born in 1997 (approximately 28 years old). She has no known drug allergies, and this has been confirmed.

Her problem list includes an active, confirmed diagnosis of mild intermittent asthma, uncomplicated (SNOMED CT 427679007; ICD-10-CM J45.20), present since childhood. Severity is documented as mild.

She has two active prescriptions for asthma:

• Albuterol: 90 mcg/actuation metered-dose inhaler (200 actuations per inhaler). She takes 2 puffs by inhalation as needed for shortness of breath. Per her instructions, she typically uses it 2–3 times per week.
• Montelukast: 10 mg oral tablet, taken once daily for maintenance.

Her most recent pulmonary function test showed an FEV1 of 92% of predicted. This result is final.

No appointments or scheduling information were included in the record.

Emily Chen is a 28-year-old female with a confirmed diagnosis of mild intermittent asthma since childhood. She has no known drug allergies. Her current medications include albuterol 90 mcg per actuation inhaler, used as 2 puffs as needed for shortness of breath (typically 2–3 times per week), and montelukast 10 mg taken daily for asthma maintenance. Her most recent pulmonary function test showed an FEV1 of 92% of predicted.

Emily Chen is a female born in 1997 with active, confirmed mild intermittent asthma, uncomplicated, documented on her problem list with onset in childhood. Her active asthma prescriptions include an albuterol 90 mcg/actuation metered-dose inhaler containing 200 actuations, with instructions to inhale 2 puffs as needed for shortness of breath. She reports typical albuterol use of 2–3 times per week. She is also prescribed montelukast 10 mg by mouth once daily as maintenance therapy for asthma. The finalized result from her most recent pulmonary function test shows an FEV1 of 92% predicted, interpreted as normal. Her allergy record confirms no known drug allergies.

Clinical Narrative

Emily Chen is a female patient born in 1995 (approximately 30 years old). She has an active diagnosis of mild intermittent asthma, which began at age 5. She has no known medication allergies.

For her asthma, she has two active prescriptions. The first is an albuterol 90 mcg/inhalation inhaler, 2 puffs as needed for shortness of breath, which she typically uses 2–3 times per week. The second is montelukast sodium 10 mg oral tablet, taken once daily. A finalized examination recorded her forced expiratory volume in one second (FEV1) at 92%.